Ani Pharmaceuticals (ANIP) Change in Account Payables (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Change in Account Payables of $5.4 million for Q1 2026, up 174.06% sequentially from -$7.2 million in Q4 2025, and down 3.44% YoY from $5.5 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Change in Account Payables (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Change in Account Payables for 15 years, with the latest figure at $5.4 million in Q1 2026.
- Quarterly Change in Account Payables fell 3.44% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (up 372.19% YoY) and the FY2025 annual result came in at $15.2 million, up 3064.09% from the prior year.
- Change in Account Payables grew to $5.4 million in Q1 2026 per ANIP's latest filing, from -$7.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $13.8 million in Q3 2025 and troughed at -$9.1 million in Q3 2022.
- A 5-year average of $2.0 million and a median of $3.1 million in 2025 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 753.23% in 2022, down 602.32% in 2022.
- Over 5 years, Change in Account Payables stood at $10.1 million in 2022, then tumbled by 72.38% to $2.8 million in 2023, then sank by 345.36% to -$6.8 million in 2024, then fell by 6.07% to -$7.2 million in 2025, then surged by 174.06% to $5.4 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $5.4 million, -$7.2 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.12 Mn |
| Jun 30, 2026 | -1.12 Mn |
| Mar 31, 2026 | 5.36 Mn |
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | -7.24 Mn |
| Dec 31, 2025 | -7.24 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Dec 31, 2024 | -6.82 Mn |
| Dec 31, 2024 | -6.82 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | 11.53 Mn |
| Mar 31, 2024 | 11.53 Mn |